Organization Name：
（组织名称） McKesson Corporation
（组织名称） McKesson Corporation
Organizational Unit：
（组织单位） McKesson Specialty Health - Risk, Evaluation, and Mitigation Strategies
（组织单位） McKesson Specialty Health - Risk, Evaluation, and Mitigation Strategies
Maturity Level：
（成熟度） Maturity Level 2
（成熟度） Maturity Level 2
Appraisal End Date：
（评估结束日期） Feb 06, 2015
（评估结束日期） Feb 06, 2015
Lead Appraiser：
（主任评估师） Rebecca Fitzgerald
（主任评估师） Rebecca Fitzgerald
Sponsor：
（发起人） Helen Welsh
（发起人） Helen Welsh
- Sampling Summary：
（抽样汇总） -
Sampling Factors: Location (Not Relevant: Location is not a factor in determining differences in work processes. Regardless of geographic location of employees or customers, processes used are the same.)
Customer (Not Relevant: The customer does not impact the processes used. This highly regulated environment does not change based on customer.)
Size (Not Relevant: The processes employed do not change based on the size of the customer or the project.)
Organizational Structure (Not Relevant: The organizational structure does not impact the processes used.)
Type of Work: The type of work directly impacts the processes used. New Programs developed are distinctly different from New Platforms adopted, although the new platforms become used by the new programs over time. (A merging occurs to bring the New Platform into productive use).Sampling Factor Values: New Programs (Type of Work): When an experimental drug is coming to clinical trials and going through the FDA approval process, it requires a Risk Evaluation and Mitigation Strategies System. McKesson”s REMS product responds to this relatively new marketplace regulatory requirement by developing a REMS program for each Drug when asked to do so by a customer. Sometimes the drug does not make it far enough through the process to bring the drug to production, and the Program is suspended. New Programs are started once or tw
New Platforms (Type of Work): In order to deliver the REMS programs, the underlying structure of the systems in place need to reflect the requirements regarding availability, maintainability, customizability, economies of scale and crucial security constraints. The architecture of the product is reviewed regularly for strategic and tactical improvements. New Platforms follow different processes than new Programs follow.Subgroups: 1. New Program: The configuration of the existing platform to accommodate a net new program (e.g. new customer, or one of a customer’s new programs). [CPMG]
12 People, 1 Basic Units
– New Programs
2. New Platform: The introduction of new services, infrastructure changes, or major enhancements to the REMS platform. [SOA]
9 People, 1 Basic Units
– New Platforms
说明：该信息摘自CMMI官网公示，更多详情请点击这里查看。注：CMMI认证有效期3年，过期链接失效。
